Advertisement
The Body: The Complete HIV/AIDS Resource
Sign up for free e-mail updates!The Body en Espanol
  • E-mail E-Mail
  • Glossary Glossary
  • Bookmark and Share Share
The Body Covers: The XIII International AIDS Conference
The Cost of Managing Abnormal Fat Distribution and Metabolic Abnormalities in France

July 12, 2000


This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document.

  • The cost of managing abnormal fat distribution and metabolic abnormalities in France (Poster, WePeB4251)
    Authored by A. Richter, S. Denett, J. Jordan, J. Doherty, S. Mahajan (United States)


Dennett, et al., from Glaxo Wellcome reported on an "expert panel" of 47 French physicians who among other things were not able to reach a consensus on the "exact definition" of abnormal fat distribution and metabolic abnormalities. They did agree that just under half of patients on protease inhibitor (PI) therapy and 15% on other antiretroviral therapy experience symptoms of these conditions. Exercise, dietary modifications and changes to the antiretroviral therapy regimen were generally recommended. Other interventions ranged from lipid-lowering drugs to growth hormone, liposuction or plastic surgery. They calculated the cost of added monitoring and intervention and found it significant (but greatly speculative). The authors concluded that, "there is currently a lack of effective therapeutic options to treat patients with fat maldistribution and metabolic abnormalities."


This article is part of TheBody.com's archive. Because it contains information that may no longer be accurate, this article should only be considered a historical document.

See Also
An HIVer's Guide to Metabolic Complications
More on Metabolic Complications


  • E-mail E-Mail
  • Glossary Glossary
  • Bookmark and Share Share

This article was provided by The Body PRO. Copyright © Body Health Resources Corporation. All rights reserved.

Please note: Knowledge about HIV changes rapidly. Note the date of this summary's publication, and before treating patients or employing any therapies described in these materials, verify all information independently. If you are a patient, please consult a doctor or other medical professional before acting on any of the information presented in this summary. For a complete listing of our most recent conference coverage, click here.

Advertisement